Literature DB >> 21431798

Cancer excess after arsenic exposure from contaminated milk powder.

Takashi Yorifuji1, Toshihide Tsuda, Hiroyuki Doi, Philippe Grandjean.   

Abstract

OBJECTIVES: Long-term exposure to inorganic arsenic is related to increased risk of cancer in the lung, skin, bladder, and, possibly, other sites. However, little is known about the consequences of developmental exposures in regard to cancer risk. During early summer in 1955, mass arsenic poisoning of infants occurred in the western part of Japan because of contaminated milk powder. Okayama Prefecture was most severely affected. We examined whether the affected birth cohorts in this prefecture experienced increased cancer mortality.
METHODS: We targeted subjects who were born from September 1950 to August 1960 and died in Okayama Prefecture between January 1969 and March 2008 due to malignant neoplasm (N = 3,141). We then compared cancer mortality (total, liver, pancreatic, lung, bladder/kidney, and hematopoietic cancers) between cohorts born before the milk poisoning (exposed group) and cohorts born after the poisoning (nonexposed group). We estimated mortality ratios and 95% confidence intervals.
RESULTS: Total and liver cancers were elevated in the cohort up to 1 year of age at time of the poisoning. In addition, pancreatic and hematopoietic cancers were elevated in the cohorts up to 5 years of age, and mortality ratios were approximately twice those of the nonexposed group. Increased risk of lung and bladder/kidney cancers was not apparent.
CONCLUSIONS: Although dilution is present in these cohort-based data, our study highlights the notion that developmental arsenic exposure may lead to a different pattern of cancer, including increases in pancreatic and hematopoietic cancer, as compared with adult or lifetime exposures to inorganic arsenic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21431798      PMCID: PMC3078290          DOI: 10.1007/s12199-010-0182-x

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  17 in total

1.  [Excess mortality among 5,064 victims of arsenic poisoning from ingestion of arsenic-contaminated "Morinaga dry-milk" in 1955: a prospective study from 1982 to 2004].

Authors:  Hideo Tanaka; Akira Oshima
Journal:  Nihon Koshu Eisei Zasshi       Date:  2007-04

2.  A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres.

Authors:  Kurt Straif; Lamia Benbrahim-Tallaa; Robert Baan; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Véronique Bouvard; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

3.  Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder.

Authors:  Takashi Yorifuji; Toshihide Tsuda; Philippe Grandjean
Journal:  J Natl Cancer Inst       Date:  2010-01-12       Impact factor: 13.506

4.  Long term low-dose arsenic exposure induces loss of DNA methylation.

Authors:  John F Reichard; Michael Schnekenburger; Alvaro Puga
Journal:  Biochem Biophys Res Commun       Date:  2006-11-10       Impact factor: 3.575

5.  Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile.

Authors:  Jane Liaw; Guillermo Marshall; Yan Yuan; Catterina Ferreccio; Craig Steinmaus; Allan H Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

Review 6.  Health effects of arsenic and chromium in drinking water: recent human findings.

Authors:  Allan H Smith; Craig M Steinmaus
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

Review 7.  Health effects of early life exposure to arsenic.

Authors:  Marie Vahter
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-02       Impact factor: 4.080

Review 8.  Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus.

Authors:  Andrea Díaz-Villaseñor; Anna L Burns; Marcia Hiriart; Mariano E Cebrián; Patricia Ostrosky-Wegman
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-31       Impact factor: 4.219

9.  Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis.

Authors:  Hua Chen; ShuanFang Li; Jie Liu; Bhalchandra A Diwan; J Carl Barrett; Michael P Waalkes
Journal:  Carcinogenesis       Date:  2004-04-08       Impact factor: 4.944

10.  Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder.

Authors:  Miwako Dakeishi; Katsuyuki Murata; Philippe Grandjean
Journal:  Environ Health       Date:  2006-10-31       Impact factor: 5.984

View more
  14 in total

1.  Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study.

Authors:  Esther García-Esquinas; Marina Pollán; Jason G Umans; Kevin A Francesconi; Walter Goessler; Eliseo Guallar; Barbara Howard; John Farley; Lyle G Best; Ana Navas-Acien
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-17       Impact factor: 4.254

2.  Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.

Authors:  Robert K Dearth; Jill K Hiney; Vinod K Srivastava; Alina M Hamilton; William L Dees
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-20

3.  Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood.

Authors:  Molly L Kile; E Andres Houseman; Andrea A Baccarelli; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; Andres Cardenas; Robert O Wright; David C Christiani
Journal:  Epigenetics       Date:  2014-02-13       Impact factor: 4.528

4.  Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice.

Authors:  Erik J Tokar; Bhalchandra A Diwan; David J Thomas; Michael P Waalkes
Journal:  Arch Toxicol       Date:  2012-03-08       Impact factor: 5.153

Review 5.  In utero and early life arsenic exposure in relation to long-term health and disease.

Authors:  Shohreh F Farzan; Margaret R Karagas; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-13       Impact factor: 4.219

6.  Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice.

Authors:  Erik J Tokar; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Toxicol Lett       Date:  2011-12-31       Impact factor: 4.372

7.  Prepubertal exposure to arsenic(III) suppresses circulating insulin-like growth factor-1 (IGF-1) delaying sexual maturation in female rats.

Authors:  Michael P Reilly; James C Saca; Alina Hamilton; Rene F Solano; Jesse R Rivera; Wendy Whitehouse-Innis; Jason G Parsons; Robert K Dearth
Journal:  Reprod Toxicol       Date:  2013-09-30       Impact factor: 3.143

Review 8.  Early-Life Arsenic Exposure, Nutritional Status, and Adult Diabetes Risk.

Authors:  Ana Navas-Acien; Miranda J Spratlen; Ahlam Abuawad; Nancy J LoIacono; Anne K Bozack; Mary V Gamble
Journal:  Curr Diab Rep       Date:  2019-11-22       Impact factor: 4.810

9.  Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cells.

Authors:  Volodymyr P Tryndyak; Barbara Borowa-Mazgaj; Colleen R Steward; Frederick A Beland; Igor P Pogribny
Journal:  Arch Toxicol       Date:  2020-08-25       Impact factor: 5.153

10.  Pancreatic cancer risk and levels of trace elements.

Authors:  André F S Amaral; Miquel Porta; Debra T Silverman; Roger L Milne; Manolis Kogevinas; Nathaniel Rothman; Kenneth P Cantor; Brian P Jackson; José A Pumarega; Tomàs López; Alfredo Carrato; Luisa Guarner; Francisco X Real; Núria Malats
Journal:  Gut       Date:  2011-12-19       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.